Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactulose and Immunotherapy in Advanced Cancer (BLOOM)
NCT07354100Phase 2Recruiting
- Sponsor
- University of Chicago
- Start
- Dec 2026
- Primary completion
- Apr 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of lactulose in cancer, melanoma, sponsored by University of Chicago. Planned start Dec 2026; status: recruiting.
02
Drugs
lactulose
03
Conditions
cancermelanoma
Beyond the preview
Go deeper on NCT07354100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07354100.